News Archive

07/05/2017

Nature Publication Reports Favorable Clinical Trial Results of BioNTech's Individualized Cancer Vaccine IVAC® MUTANOME

- First-ever clinical study demonstrates personalized RNA-based vaccine using mutant neo-epitopes as antigens activates immune system against individual… Read more

05/13/2016

Bayer and BioNTech Join Forces to Develop Innovative New mRNA Vaccines and Therapeutics for Animal Health Applications

Leverkusen / Mainz, Germany, May 10, 2016 - Bayer and BioNTech AG, a leading immunotherapy company headquartered in Mainz, Germany have entered into an… Read more

07/19/2013

Doing a career together in the Rhine-Main-Region - “Mainzer Wissenschaftsallianz” joins the network supporting dual career partnerships

Frankfurt / Attracting highly qualified couples to the Rhine-Main-Area is the goal of the network, which was founded by four universities and eleven external… Read more

06/07/2013

The „MAINZER WISSENSCHAFTSALLIANZ” has become a registered association

On June 7, 2013 the up until now loose network “MAINZER WISSENSCHAFTSALLIANZ” or “Sciences Alliance of Mainz” was formed into a registered non-profit… Read more

09/30/2011

The President of Mainz University of Applied Sciences, Professor Dr. Gerhard Muth, appointed new Coordinator of the MAINZ RESEARCH ALLIANCE

The President of Mainz University, Professor Dr. Georg Krausch, to step down as Coordinator on 1 October 2011 / Continuing expansion of knowledge exchange and… Read more

• previous
• 1
• 2